NEWS
Our Latest News
ARCHIMED buys Denmark’s DermaPharm A/S, a leading developer and manufacturer of skincare products
Global private equity healthcare specialist ARCHIMED announces the acquisition of DermaPharm A/V. DermaPharm is a leading player in Nordic suncare and a world-renowned skincare contract development & manufacturing organization for third parties.
ARCHIMED buys Cube, an innovative provider of membrane protein services for the biopharma research market
November
3,
2021
ARCHIMED refinances Ad-Tech less than a year after purchase, returning more than a third of investment to shareholders
October
20,
2021
ARCHIMED’s NAMSA returns more than a third of investment
October
7,
2021
368